-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
Iterum Therapeutics plc quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate for Q3 2025.
- Iterum Therapeutics plc Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 30, 2025 was $448K.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)